KVUEKenvue Inc.
- BusinessWire
Kenvue Reports Second Quarter 2026 Results
Delivered Third Consecutive Quarter of Net and Organic Sales1 Growth Net Sales Increased 3.0%; Organic Sales Increased 1.6% Diluted EPS Increased 9% to $0.24; Adjusted Diluted EPS1 Increased 7% to ...
- BusinessWire
Kenvue Increases Quarterly Cash Dividend
Kenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock, which represents a 1.2 percent increase compared to the prior quarterly ...
- BusinessWire
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026
Kenvue Inc. (NYSE:KVUE) will announce its second quarter 2026 financial results before the market opens on August 6, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly ...
- Analyst Upgrades
Barclays Maintains Equal-Weight on Kenvue, Raises Price Target to $19
Barclays analyst Lauren Lieberman maintains Kenvue with a Equal-Weight and raises the price target from $18 to $19. ...
- Analyst Upgrades
UBS Maintains Neutral on Kenvue, Raises Price Target to $20
UBS analyst Peter Grom maintains Kenvue with a Neutral and raises the price target from $18 to $20. ...
- CNBC
Jim Cramer says these are the 5 stocks to buy during this market rotation
CNBC's Jim Cramer said investors should use the latest market rotation as an opportunity to buy high-quality companies. ...
- Reuters
Mondelez names consumer goods veteran Amit Banati as CFO
Chocolate maker Mondelez International on Monday named former Kellogg executive Amit Banati as its new chief financial officer, effective July 1. ...
- CNBC
Jim Cramer says look to buy these 5 stocks outside the AI trade for diversification
CNBC's Jim Cramer said investors should consider adding exposure to out-of-favor sectors if investors begin rotating away from high-flying technology stocks. ...
- Reuters
Kenvue beats first-quarter estimates amid pending acquisition by Kimberly-Clark
Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by strong sales in its skin health and beauty brands. ...
- BusinessWire
Kenvue Reports First Quarter 2026 Results
Net Sales Increased 4.5%; Organic Sales1 Increased 0.7% Diluted EPS Increased 47% to $0.25; Adjusted Diluted EPS1 Increased 33% to $0.32 Kenvue Inc. (NYSE:KVUE) today announced financial results for the fiscal ...
- BusinessWire
Kenvue Declares Quarterly Cash Dividend
Kenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on May 27, 2026, to shareholders of record as ...
- Reuters
Kimberly-Clark sticks to 2026 outlook, beats sales estimates on steady demand
Kimberly-Clark kept its annual forecast intact and beat first-quarter sales estimates on Tuesday, as lower prices at the Kleenex tissue maker helped draw budget-strained consumers amid persisting geopolitical and macroeconomic uncertainties. ...
- BusinessWire
Kenvue to Announce First Quarter 2026 Results on May 7, 2026
Kenvue Inc. (NYSE:KVUE) will announce its first quarter 2026 financial results before the market opens on May 7, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly ...
- PR Newswire
Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership
Kimberly‑Clark Corporation (NASDAQ: KMB) today announced the organizational structure and key leadership that will become effective upon completion... ...
- Analyst Upgrades
UBS Maintains Neutral on Kenvue, Lowers Price Target to $18
UBS analyst Peter Grom maintains Kenvue with a Neutral and lowers the price target from $19 to $18. ...
- Analyst Upgrades
Barclays Maintains Equal-Weight on Kenvue, Raises Price Target to $19
Barclays analyst Lauren Lieberman maintains Kenvue with a Equal-Weight and raises the price target from $18 to $19. ...
- Reuters
Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol's safety
A Texas judge on Thursday rejected Kenvue's bid to dismiss a lawsuit by state Attorney General Ken Paxton accusing the company of falsely marketing Tylenol by concealing autism and other risks to children when pregnant women use the popular painkiller. ...
- Analyst Upgrades
Canaccord Genuity Maintains Hold on Kenvue, Raises Price Target to $18
Canaccord Genuity analyst Susan Anderson maintains Kenvue with a Hold and raises the price target from $17 to $18. ...
- Analyst Upgrades
Citigroup Maintains Neutral on Kenvue, Raises Price Target to $20
Citigroup analyst Filippo Falorni maintains Kenvue with a Neutral and raises the price target from $18 to $20. ...
- Analyst Upgrades
UBS Maintains Neutral on Kenvue, Raises Price Target to $19
UBS analyst Peter Grom maintains Kenvue with a Neutral and raises the price target from $17 to $19. ...
- BusinessWire
Kenvue Reports Fourth Quarter and Full Year 2025 Results
Q4 Net Sales 3.2%; Organic Sales1 1.2% Q4 Diluted EPS was $0.17; Adjusted Diluted EPS1 was $0.27 FY'25 Net Sales (2.1)%; Organic Sales (2.2)% FY'25 Diluted EPS was $0.76; Adjusted Diluted EPS was ...
- BusinessWire
Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026
Kenvue Inc. (NYSE:KVUE) will announce its fourth quarter and full year 2025 financial results after market close on February 17, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a ...
- Analyst Upgrades
Jefferies Downgrades Kenvue to Hold, Lowers Price Target to $18
Jefferies analyst Keith Devas downgrades Kenvue from Buy to Hold and lowers the price target from $23 to $18. ...
- PR Newswire
Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue
Kimberly-Clark Corporation (NASDAQ: KMB) and Kenvue Inc. (NYSE: KVUE) today announced that Kimberly-Clark and Kenvue shareholders voted... ...
- BusinessWire
Kenvue Declares Quarterly Cash Dividend
Kenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on February 25, 2026, to shareholders of ...